Keebeck Alpha, LP Adaptive Biotechnologies Corp Transaction History

Keebeck Alpha, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$6.19 - $8.78 $37,765 - $53,566	-6,101 Reduced 16.14%	31,699 $212,000
Q1 2023 May 11, 2023	BUY	$7.8 - $10.11 $128,840 - $166,996	16,518 Added 77.61%	37,800 $333,000
Q3 2022 Nov 07, 2022	BUY	$6.5 - $12.67 $138,333 - $269,642	21,282 New	21,282 $152,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.